{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:15:57Z","timestamp":1793646957065,"version":"4.5.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kisupplements.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Supplements"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.kisu.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T04:21:11Z","timestamp":1514521271000},"page":"2-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":289,"title":["Diagnosis of diabetic kidney disease: state of the art and future perspective"],"prefix":"10.1016","volume":"8","author":[{"given":"Frederik","family":"Persson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kisu.2017.10.003_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.kisu.2017.10.003_bib2","first-page":"336","article-title":"The prognosis of insulin-dependent diabetes mellitus. An epidemiological approach","volume":"39","author":"Borch-Johnsen","year":"1989","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.kisu.2017.10.003_bib3","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2215\/CJN.02870316","article-title":"Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: the DCCT\/EDIC Study","volume":"11","author":"de Boer","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF00400995","article-title":"Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients","volume":"34","author":"Gall","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.kisu.2017.10.003_bib5","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA Consensus Conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ki.2014.206","article-title":"Improved prognosis of diabetic nephropathy in type 1 diabetes","volume":"87","author":"Andresdottir","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kisu.2017.10.003_bib7","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/dc13-2036","article-title":"Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors","volume":"37","author":"Andresdottir","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib8","first-page":"1411","article-title":"Diabetic nephropathy","volume":"Vol. 1","author":"Parving","year":"2012"},{"key":"10.1016\/j.kisu.2017.10.003_bib9","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.2337\/dc17-S013","article-title":"Microvascular Complications and Foot Care","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib10","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa021835","article-title":"Regression of microalbuminuria in type 1 diabetes","volume":"348","author":"Perkins","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kisu.2017.10.003_bib11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.38070.450891.FE","article-title":"Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study","volume":"328","author":"Hovind","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.kisu.2017.10.003_bib12","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/ndt\/gfh470","article-title":"Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria","volume":"19","author":"Gaede","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kisu.2017.10.003_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2337\/dc11-1380","article-title":"Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study","volume":"35","author":"Solini","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib14","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.2337\/dc15-0641","article-title":"The presence and consequence of nonalbuminuric chronic kidney disease in patients with type 1 diabetes","volume":"38","author":"Thorn","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib15","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kisu.2017.10.003_bib16","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guideline for diabetes and CKD: 2012 Update","volume":"60","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kisu.2017.10.003_bib17","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/sj.ki.5000377","article-title":"Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective","volume":"69","author":"Parving","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kisu.2017.10.003_bib18","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1681\/ASN.2010010063","article-title":"Comparison of different measures of urinary protein excretion for prediction of renal events","volume":"21","author":"Lambers Heerspink","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kisu.2017.10.003_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2147\/CLEP.S99518","article-title":"The Danish Adult Diabetes Registry","volume":"8","author":"Jorgensen","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.kisu.2017.10.003_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ndt\/gfs567","article-title":"Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort","volume":"28","author":"Hellemons","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kisu.2017.10.003_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kisu.2017.10.003_bib23","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/dc12-1298","article-title":"Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy","volume":"36","author":"Araki","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/dc09-2242","article-title":"Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients","volume":"33","author":"Nielsen","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/dc07-2469","article-title":"Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy","volume":"31","author":"Nguyen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2337\/dc07-1960","article-title":"Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate","volume":"31","author":"Astrup","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib27","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib30","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.2337\/dc14-0225","article-title":"Added value of soluble tumor necrosis factor alpha receptor-1 as a biomarker of ESRD risk in patients with type 1 diabetes","volume":"37","author":"Forsblom","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kisu.2017.10.003_bib31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1681\/ASN.2011060628","article-title":"Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes","volume":"23","author":"Gohda","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib32","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.kint.2016.10.046","article-title":"Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes","volume":"91","author":"Krolewski","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kisu.2017.10.003_bib33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1365-2362.2012.02674.x","article-title":"Implementation of proteomic biomarkers: making it work","volume":"42","author":"Mischak","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.kisu.2017.10.003_bib34","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ki.2015.199","article-title":"Biomarkers of rapid chronic kidney disease progression in type 2 diabetes","volume":"88","author":"Looker","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kisu.2017.10.003_bib35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1681\/ASN.2007050582","article-title":"ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy","volume":"19","author":"Parving","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00125-014-3459-6","article-title":"SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes","volume":"58","author":"Germain","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.kisu.2017.10.003_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002921","article-title":"New susceptibility loci associated with kidney disease in type 1 diabetes","volume":"8","author":"Sandholm","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.kisu.2017.10.003_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1681\/ASN.2016020231","article-title":"The genetic landscape of renal complications in type 1 diabetes","volume":"28","author":"Sandholm","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.568","article-title":"New loci associated with kidney function and chronic kidney disease","volume":"42","author":"Kottgen","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.kisu.2017.10.003_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12265-012-9382-7","article-title":"Perspectives on systems biology applications in diabetic kidney disease","volume":"5","author":"Komorowsky","year":"2012","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.kisu.2017.10.003_bib41","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00125-016-4021-5","article-title":"JAK inhibition in the treatment of diabetic kidney disease","volume":"59","author":"Brosius","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.kisu.2017.10.003_bib42","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/dme.12447","article-title":"Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus","volume":"31","author":"Pena","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/j.kisu.2017.10.003_bib43","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jc.2015-3345","article-title":"Prediction of declining renal function and albuminuria in patients with type 2 diabetes by metabolomics","volume":"101","author":"Solini","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kisu.2017.10.003_bib44","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/ki.2013.497","article-title":"Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study","volume":"85","author":"Niewczas","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kisu.2017.10.003_bib45","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease","volume":"9","author":"Good","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.kisu.2017.10.003_bib46","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.2337\/db12-0348","article-title":"Urinary proteomics for early diagnosis in diabetic nephropathy","volume":"61","author":"Zurbig","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.kisu.2017.10.003_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00125-012-2755-2","article-title":"A\u00a0urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus","volume":"56","author":"Roscioni","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.kisu.2017.10.003_bib48","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1681\/ASN.2014050423","article-title":"Diagnosis and prediction of CKD progression by assessment of urinary peptides","volume":"26","author":"Schanstra","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kisu.2017.10.003_bib49","doi-asserted-by":"crossref","unstructured":"Lindhardt M, Persson F, Zurbig P, et\u00a0al. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study [e-pub ahead of print]. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfw292.","DOI":"10.1093\/ndt\/gfw292"},{"key":"10.1016\/j.kisu.2017.10.003_bib50","doi-asserted-by":"crossref","unstructured":"Siwy J, Zurbig P, Argiles A, et\u00a0al. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis [e-pub ahead of print]. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfw337.","DOI":"10.1093\/ndt\/gfw337"}],"container-title":["Kidney International Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2157171617300606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2157171617300606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T08:17:24Z","timestamp":1658132244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2157171617300606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2157171617300606"],"URL":"https:\/\/doi.org\/10.1016\/j.kisu.2017.10.003","relation":{},"ISSN":["2157-1716"],"issn-type":[{"value":"2157-1716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of diabetic kidney disease: state of the art and future perspective","name":"articletitle","label":"Article Title"},{"value":"Kidney International Supplements","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kisu.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}